Keywords

MetaboliteIn vivoCholesterolBile ductGlucuronideChemistryMetabolismBile acidActive metabolitePharmacokineticsAbsorption (acoustics)PharmacologyInternal medicineBiochemistryEndocrinologyBiologyMedicine

Related Publications

Discovery of 1-(4-Fluorophenyl)-(3<i>R</i>)-[3-(4-fluorophenyl)-(3<i>S</i>)- hydroxypropyl]-(4<i>S</i>)-(4-hydroxyphenyl)-2-azetidinone (SCH 58235):  A Designed, Potent, Orally Active Inhibitor of Cholesterol Absorption

Stuart B. Rosenblum , Tram Huynh , Adriano Afonso +4 more

(3R)-(3-Phenylpropyl)-1,(4S)-bis(4-methoxyphenyl)-2-azetidinone (2, SCH 48461), a novel inhibitor of intestinal cholesterol absorption, has recently been described by Burnett et...

1998 Journal of Medicinal Chemistry 351 citations

Publication Info

Year
1997
Type
article
Volume
283
Issue
1
Pages
157-163
Citations
304
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

304
OpenAlex

Cite This

Margaret van Heek, Constance F. France, Douglas S. Compton et al. (1997). In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461. Journal of Pharmacology and Experimental Therapeutics , 283 (1) , 157-163. https://doi.org/10.1016/s0022-3565(24)36992-7

Identifiers

DOI
10.1016/s0022-3565(24)36992-7